1887
  1. Home
  2. Eurosurveillance
  3. Volume 30, Issue 44, 06/Nov/2025
  4. Article
Outbreaks Open Access
Like 0
Download

Abstract

In Spain during March–April 2024, an outbreak of invasive meningococcal disease (IMD) occurred in four young adults, exhibiting high case fatality with two deaths. Cases 1 and 4 were confirmed by isolation of from blood samples, while Cases 2 and 3 were PCR-confirmed from cerebrospinal fluid (CSF). Serogroup B meningococcus with identical characterisation (B: 19–54, 15: F5–1: ST-34, cc32) was identified for all cases; the outbreak strain genosubtype PorA_VR1: 19–54 had not been previously described. Potential coverage of the outbreak strain by available MenB vaccines could not be predicted by molecular tools, so bactericidal response to the 4CMenB vaccine against the outbreak strain was measured by human serum bactericidal antibody assay (hSBA), defining the strain as covered by the vaccine. Two different social events were involved in transmission of the outbreak strain. According to the national meningococcal disease surveillance protocol, an active search for close contacts of the cases was conducted by public health authorities and timely chemoprophylaxis and/or vaccination with 4CMenB vaccine was recommended to over 200 contacts. The evolution of meningococcal strains with genosubtype 19–54 should be closely monitored, as it might confer a greater transmission capacity.

© Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2025.30.44.2500222
2025-11-06
2025-12-05
/content/10.2807/1560-7917.ES.2025.30.44.2500222
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/30/44/eurosurv-30-44-2.html?itemId=/content/10.2807/1560-7917.ES.2025.30.44.2500222&mimeType=html&fmt=ahah

References

  1. Borrow R, Findlow J. The important lessons lurking in the history of meningococcal epidemiology. Expert Rev Vaccines. 2024;23(1):445-62.  https://doi.org/10.1080/14760584.2024.2329618  PMID: 38517733 
  2. European Centre for Disease Prevention and Control. Invasive meningococcal disease. In: ECDC. Annual epidemiological report for 2022. Stockholm: ECDC; 2024. Available from: (https://www.ecdc.europa.eu/sites/default/files/documents/invasive-meningococcal-disease-annual-epidmeiological-report-2022.pdf)
  3. Shaw D, Abad R, Amin-Chowdhury Z, Bautista A, Bennett D, Broughton K, et al. Trends in invasive bacterial diseases during the first 2 years of the COVID-19 pandemic: analyses of prospective surveillance data from 30 countries and territories in the IRIS Consortium. Lancet Digit Health. 2023;5(9):e582-93.  https://doi.org/10.1016/S2589-7500(23)00108-5  PMID: 37516557 
  4. Clark SA, Campbell H, Ribeiro S, Bertran M, Walsh L, Walker A, et al. Epidemiological and strain characteristics of invasive meningococcal disease prior to, during and after COVID-19 pandemic restrictions in England. J Infect. 2023;87(5):385-91.  https://doi.org/10.1016/j.jinf.2023.09.002  PMID: 37689395 
  5. Taha S, Hong E, Denizon M, Falguières M, Terrade A, Deghmane AE, et al. The rapid rebound of invasive meningococcal disease in France at the end of 2022. J Infect Public Health. 2023;16(12):1954-60.  https://doi.org/10.1016/j.jiph.2023.10.001  PMID: 37875044 
  6. Pardo de Santayana C, Tin Tin Htar M, Findlow J, Balmer P. Epidemiology of invasive meningococcal disease worldwide from 2010-2019: a literature review. Epidemiol Infect. 2023;151:e57.  https://doi.org/10.1017/S0950268823000328  PMID: 37052295 
  7. Soler-Soneira M, Alcaide-Jimenez A, Muñoz-Martinez L, Castellares-González CI, Cano Portero R. Enfermedad meningocócica invasiva en España en 2023. Bol Epidemiol Sem (Madr). 2024;32(4):194-208.  https://doi.org/10.4321/s2173-92772024000400005 
  8. Abad R, Navarro C, García-Amil C, Martín E, Montes M, Camacho J, et al. Enfermedad Meningocócica Invasiva (2020-2022). In Echevarria Mayo J. E.; Oteo Iglesias J.; Jado Garcia I. (editores). Programas de Vigilancia Microbiológica Centro Nacional de Microbiología. Volumen 2. 2021-2022 Majadahonda (Madrid); Instituto de Salud Carlos III, Centro Nacional de Microbiología: 2023. Available from: https://repisalud.isciii.es/rest/api/core/bitstreams/b559792d-6b4b-4f43-9a17-7e53247ec0c7/content
  9. Sáez-Nieto JA, Perucha M, Casamayor H, Marcen JJ, Llacer A, Garcia-Barreno B, et al. Outbreak of infection caused by Neisseria meningitidis group C type 2 in a nursery. J Infect. 1984;8(1):49-55.  https://doi.org/10.1016/S0163-4453(84)93327-9  PMID: 6699414 
  10. Lepe JA, Salcedo C, Alcalá B, Vázquez JA. [Evolution of Neisseria meningitidis sensitivity to various antimicrobial drugs over the course of chemoprophylaxis during an epidemic outbreak]. Enferm Infecc Microbiol Clin. 2006;24(10):608-12.  https://doi.org/10.1157/13095371  PMID: 17194385 
  11. Consejo Interterritorial, Sistema Nacional de Salud. Calendario común de vacunaciones e inmunizaciones a lo largo de toda la vida. Calendario recomendado año 2024. [Common vaccination and immunization schedule throughout lifetime]. Madrid: Ministerio de Sanidad. [Accessed: 14 Mar 2025]. Available from: https://www.sanidad.gob.es/areas/promocionPrevencion/vacunaciones/calendario/docs/CalendarioVacunacion_Todalavida.pdf
  12. Instituto de Salud Carlos III. Protocolos de la Red Nacional de Vigilancia Epidemiológica. [Protocols of the National Epidemiological Surveillance Network]. Madrid: Ministerio de Ciencia Innovacion y Universidades. [Accessed: 14 Mar 2025]. Available from: https://cne.isciii.es/documents/d/cne/protocolo-de-vigilancia-de-enfermedad-meningococica-pdf
  13. European Commission. Commission decision of 22 June 2018 2018/945 amending decision 1082/2013/EU on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definition. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 6.7.2018: L170/30. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945
  14. Abad R, García-Amil C, Navarro C, Martín E, Martín-Díaz A, Vázquez JA. Molecular characterization of invasive serogroup B Neisseria meningitidis isolates from Spain during 2015-2018: Evolution of the vaccine antigen factor H binding protein (FHbp). J Infect. 2021;82(4):37-44.  https://doi.org/10.1016/j.jinf.2021.01.030  PMID: 33610688 
  15. Fernández-Rodríguez A, Alcalá B, Alvarez-Lafuente R. Real-time polymerase chain reaction detection of Neisseria meningitidis in formalin-fixed tissues from sudden deaths. Diagn Microbiol Infect Dis. 2008;60(4):339-46.  https://doi.org/10.1016/j.diagmicrobio.2007.10.014  PMID: 18068935 
  16. Soler-Garcia A, Fernández de Sevilla M, Abad R, Esteva C, Alsina L, Vázquez J, et al. Meningococcal Serogroup B Disease in Vaccinated Children. J Pediatric Infect Dis Soc. 2020;9(4):454-9.  https://doi.org/10.1093/jpids/piz071  PMID: 31634404 
  17. The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters. Version 14.0, 2024. Available from. http://www.eucast.org.
  18. Muzzi A, Brozzi A, Serino L, Bodini M, Abad R, Caugant D, et al. Genetic Meningococcal Antigen Typing System (gMATS): A genotyping tool that predicts 4CMenB strain coverage worldwide. Vaccine. 2019;37(7):991-1000.  https://doi.org/10.1016/j.vaccine.2018.12.061  PMID: 30661831 
  19. Rodrigues CMC, Jolley KA, Smith A, Cameron JC, Feavers IM, Maiden MCJ. Meningococcal Deduced Vaccine Antigen Reactivity (MenDeVAR) Index: a rapid and accessible tool that exploits genomic data in public health and clinical microbiology applications. J Clin Microbiol. 2020;59(1):e02161-20.  https://doi.org/10.1128/JCM.02161-20  PMID: 33055180 
  20. Abad R, Biolchi A, Moschioni M, Giuliani MM, Pizza M, Vázquez JA. A large portion of meningococcal antigen typing system-negative meningococcal strains from Spain is killed by sera from adolescents and infants immunized with 4CMenB. Clin Vaccine Immunol. 2015;22(4):357-60.  https://doi.org/10.1128/CVI.00669-14  PMID: 25630407 
  21. Bratcher HB, Corton C, Jolley KA, Parkhill J, Maiden MC. A gene-by-gene population genomics platform: de novo assembly, annotation and genealogical analysis of 108 representative Neisseria meningitidis genomes. BMC Genomics. 2014;15(1):1138.  https://doi.org/10.1186/1471-2164-15-1138  PMID: 25523208 
  22. Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124.  https://doi.org/10.12688/wellcomeopenres.14826.1  PMID: 30345391 
  23. Serruto D, Bottomley MJ, Ram S, Giuliani MM, Rappuoli R. The new multicomponent vaccine against meningococcal serogroup B, 4CMenB: immunological, functional and structural characterization of the antigens. Vaccine. 2012;30(0 2) Suppl 2;B87-97.  https://doi.org/10.1016/j.vaccine.2012.01.033  PMID: 22607904 
  24. Gandhi A, Balmer P, York LJ. Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®). Postgrad Med. 2016;128(6):548-56.  https://doi.org/10.1080/00325481.2016.1203238  PMID: 27467048 
Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare porA genosubtype (19-54, 15), Spain, March to April 2024
<p class="citation"> <span>Citation style for this article:</span> <span class="meta-value authors"> <a href="/search?value1=Raquel+Abad&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Abad Raquel</a>, <a href="/search?value1=Carmen+Navarro&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Navarro Carmen</a>, <a href="/search?value1=Cristina+Garc%C3%ADa-Amil&option1=author&noRedirect=true" class="nonDisambigAuthorLink">García-Amil Cristina</a>, <a href="/search?value1=Marina+Montes&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Montes Marina</a>, <a href="/search?value1=Alfredo+Casta%C3%B1eda-Garc%C3%ADa&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Castañeda-García Alfredo</a>, <a href="/search?value1=Juan+A+Cuadros&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Cuadros Juan A</a>, <a href="/search?value1=Alicia+Galar&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Galar Alicia</a>, <a href="/search?value1=Fernando+Martin&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Martin Fernando</a>, <a href="/search?value1=Ester+Mena&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Mena Ester</a>, <a href="/search?value1=Sara+P%C3%A9rez+de+Madrid&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Pérez de Madrid Sara</a>, <a href="/search?value1=Carmen+Rom%C3%A1n&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Román Carmen</a>, <a href="/search?value1=Marta+Soler&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Soler Marta</a>, <a href="/search?value1=Julio+A+V%C3%A1zquez&option1=author&noRedirect=true" class="nonDisambigAuthorLink">Vázquez Julio A</a></span>. Outbreak of invasive meningococcal disease caused by a meningococcus serogroup B expressing a rare porA genosubtype (19-54, 15), Spain, March to April 2024. <a href="/content/ecdc">Euro Surveill.</a> 2025;30(44):pii=2500222. <a href="https://doi.org/10.2807/1560-7917.ES.2025.30.44.2500222" title="doi link" target="_blank">https://doi.org/10.2807/1560-7917.ES.2025.30.44.2500222</a> <span class="ES_Article_citation"> <span class="generated">Received</span>: 26 Mar 2025;&nbsp;&nbsp; <span class="generated">Accepted</span>: 03 Jun 2025 </span> </p>
/content/10.2807/1560-7917.ES.2025.30.44.2500222
/content/10.2807/1560-7917.ES.2025.30.44.2500222
Loading

Data & Media loading...

Supplementary data

Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error